Cannabis Stock Gainers And Losers From June 27, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 46.08% at $0.02
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from MGC Pharmaceuticals
CBD And CBG Show Promising Results In Treating Glioblastoma Brain Tumors
MGC Pharmaceuticals (LON: MXC), a publicly-traded cannabis company, recently finalized pre-clinical trial research of cannabinoids as a potential treatment for glioblastoma, an aggressive brain cancer. The results were positive,
Benzinga ·
Cannabis Stock Movers For May 11, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 28.38% at $0.02
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Marijuana Stock Movers For April 14, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 50.00% at $0.02
Benzinga ·
Marijuana Stock Movers For March 21, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 40.67% at $0.02
Benzinga ·
Marijuana Stock Movers For March 16, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 21.45% at $0.02
Benzinga ·
Marijuana Stock Movers For March 9, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 19.41% at $0.02
Benzinga ·
Cannabis Stock Gainers And Losers From January 27, 2022
GAINERS:
MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.27% at $0.03
Benzinga ·
Coverage From
Benzinga
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
